EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

68 Ga-Labeled Glycopeptides as Effective Tools for Liver Function Imaging

Maximilian Alexander Zierke iD, Christine Rangger, Kimia Samadikhah, Andreas Martin Schmid, Roland Haubner iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Maximilian Alexander Zierke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Glycopeptides, Liver, Radiopharmaceuticals. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[99mTc]Tc-GSA, an albumin-based glycoprotein, is routinely used in Japan to measure the asialoglycoprotein receptor (ASGR) density via single photon emission tomography. Here we describe the development of 68Ga-labeled peptide-based alternatives. Peptides were assembled on a solid support using a fragment coupling strategy. Glycosylation was carried out via a click chemistry approach resulting in a set of three peptides with increasing amounts of d-galactose (n = 3, 6, and 9) as well as one glycopeptide bearing nine N-acetylgalactosamine residues. 68Ga-labeling of all compounds could be achieved in high radiochemical yields (>95%). Radiotracers exhibited high hydrophilicity, good metabolic stability in human serum and protein binding between 12 and 22%. The IC50 values improved in the series tri-, hexa-, and nonamer with an IC50 of 50 ± 30 pM for the latter one. In analogy, the in vivo biodistribution studies revealed increased liver uptake in the series of [68Ga]Ga-NODAGA-TriLysan (9.4 ± 2.0% ID/g, 30 min p.i.), [68Ga]Ga-NODAGA-HexaLysan (55.5 ± 7.4% ID/g, 30 min p.i.), and [68Ga]Ga-NODAGA-NonaLysan (79.6 ± 8.0% ID/g, 30 min p.i.). [68Ga]Ga-NODAGA-GalNAc-NonaLysan reached comparable liver uptake to [68Ga]Ga-NODAGA-NonaLysan, but showed higher accumulation in nontarget organs. The impressive imaging properties of [68Ga]Ga-NODAGA-NonaLysan were also confirmed by the PET/MR imaging studies in mice. Hence, [68Ga]Ga-NODAGA-NonaLysan represents a new PET radiopharmaceutical with even better imaging properties than [99mTc]Tc-GSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesGlycopeptidesLiverRadiopharmaceuticalsAnimalsMiceHumansTissue DistributionAsialoglycoprotein ReceptorClick ChemistryTomography, Emission-Computed, Single-Photon

Stichwörter der Autor:innen

Asialoglycoprotein receptorfunctional liver imaginggallium-68glycopeptidespositron emission tomography

Substanzen

Gallium RadioisotopesGlycopeptidesRadiopharmaceuticalsAsialoglycoprotein ReceptorGallium-68

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria.
  • Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 13, Tübingen 73076, Germany.

ORCID-Profile: Maximilian Alexander Zierke, Roland Haubner

Förderung

  • Austrian Science Fund
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Zierke, M. A., Rangger, C., Samadikhah, K., Schmid, A. M., & Haubner, R. (2025). 68 Ga-Labeled Glycopeptides as Effective Tools for Liver Function Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01453

Vancouver

Zierke MA, Rangger C, Samadikhah K, Schmid AM, Haubner R. 68 Ga-Labeled Glycopeptides as Effective Tools for Liver Function Imaging. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01453

BibTeX
@article{Zierke2025,
  author = {Zierke, Maximilian Alexander and Rangger, Christine and Samadikhah, Kimia and Schmid, Andreas Martin and Haubner, Roland},
  title = {68 Ga-Labeled Glycopeptides as Effective Tools for Liver Function Imaging},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01453}
}
Kostenlos starten →